An 81-year-old man became the second person Receive a COVID-19 vaccine in the UK On Tuesday, but it attracted worldwide attention because of his name: William Shakespeare.
Shakespeare, who hails from Warwickshire, the county in which the famous English poet was born, took a bullet in Coventry University Hospital. Shortly after receiving the Pfizer / BioNTech vaccine, Shakespeare said he was a “pioneer” for him to get a vaccine.
“It can make a difference in our lives from now on, right?” He said. “It has started to change our lives and our way of life.”
The first 800,000 doses of Pfizer vaccine in the UK go to people over the age of 80 who are either hospitalized or already have outpatient appointments, along with nursing home workers. The UK is taking a head start on the project after British regulators gave emergency authorization on December 2 for a vaccine produced by US pharmaceutical company Pfizer and Germany’s BioNTech. The first recipient was Grandma Margaret Keenan, who turns 91 next week.
As for Shakespeare, the name ’80s has met with a mild response from many puns mostly online to late Shakespeare works such as “The Taming of the Shrew” and “Gentlemen of Verona.”
One user referred to “Hamlet” in A. tweet About the most famous patient in England: “If Margaret Kennan was patient number 1a for the vaccine, would William Shakespeare be 2b or not 2b …”
In response to a tweet, a woman who claimed to be Shakespeare’s niece said he would like to see his family soon.
She said, “This is my beautiful uncle you are talking about.” “And at some point he would like to see his wife, children and grandchildren who cannot visit him at the moment. He is a very worthy recipient.”
British Health Secretary Matt Hancock appears to have shed a teardrop in a TV interview upon hearing that Shakespeare got his vaccine.
He said, “It was a difficult year for a lot of people and there is William Shakespeare simply putting it, for everyone, so that we can continue our lives.”
The US and European Union authorities are also reviewing Shakespeare’s vaccine, along with competing products developed by the US biotechnology company Moderna, and despite a collaboration between Oxford University and the pharmaceutical company AstraZeneca.
